Pacific Shuanglin Bio pharmacy Co Ltd Cash Flow Quality Index
Pacific Shuanglin Bio pharmacy Co Ltd cash flow quality index. Pacific Shuanglin Bio pharmacy Co Ltd (000403) has a Cash Flow Quality Index of 0.58x as of September 2025. Operating cash flow of CN¥70.28 Million is below net income of CN¥121.39 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Pacific Shuanglin Bio pharmacy Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Pacific Shuanglin Bio pharmacy Co Ltd (1998–2025)
Cash flow quality index of Pacific Shuanglin Bio pharmacy Co Ltd from 1998 to 2025. Historical Cash Flow Quality Index for Pacific Shuanglin Bio pharmacy Co Ltd across 23 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 000403 net asset quality index to measure how much of total assets are equity-financed.
Pacific Shuanglin Bio pharmacy Co Ltd Cash Flow Quality Index by Year (1998–2025)
Pacific Shuanglin Bio pharmacy Co Ltd cash flow quality index by year from 1998 to 2025. Year-by-year earnings quality comparison for Pacific Shuanglin Bio pharmacy Co Ltd. For the full cash flow conversion analysis, see how efficiently does Pacific Shuanglin Bio pharmacy Co Ltd generate cash.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.52x | CN¥-215.99 Million | CN¥419.27 Million | ▼ -219.3% |
| 2024 | 0.43x | CN¥321.79 Million | CN¥745.04 Million | ▼ -61.1% |
| 2023 | 1.11x | CN¥679.01 Million | CN¥611.47 Million | ▲ +24.5% |
| 2022 | 0.89x | CN¥524.22 Million | CN¥587.69 Million | ▼ -14.4% |
| 2021 | 1.04x | CN¥408.22 Million | CN¥391.54 Million | ▼ -2.2% |
| 2020 | 1.07x | CN¥194.84 Million | CN¥182.68 Million | ▼ -11.8% |
| 2019 | 1.21x | CN¥190.84 Million | CN¥157.84 Million | ▼ -22.3% |
| 2018 | 1.56x | CN¥116.63 Million | CN¥74.94 Million | ▲ +238.5% |
| 2017 | -1.12x | CN¥-35.91 Million | CN¥31.96 Million | ▼ -179.7% |
| 2016 | 1.41x | CN¥62.49 Million | CN¥44.32 Million | ▲ +34.0% |
| 2015 | 1.05x | CN¥70.31 Million | CN¥66.84 Million | ▲ +46.0% |
| 2014 | 0.72x | CN¥77.04 Million | CN¥106.93 Million | ▼ -49.3% |
| 2013 | 1.42x | CN¥91.01 Million | CN¥64.01 Million | ▼ -97.1% |
| 2012 | 48.61x | CN¥123.24 Million | CN¥2.54 Million | ▲ +47.5% |
| 2011 | 32.96x | CN¥130.14 Million | CN¥3.95 Million | ▲ +8077.6% |
| 2008 | 0.40x | CN¥74.90 Million | CN¥185.83 Million | ▼ -68.2% |
| 2007 | 1.27x | CN¥95.03 Million | CN¥74.93 Million | ▲ +177.2% |
| 2003 | -1.64x | CN¥-49.47 Million | CN¥30.10 Million | ▼ -148.9% |
| 2002 | 3.36x | CN¥159.18 Million | CN¥47.34 Million | ▲ +207.7% |
| 2001 | 1.09x | CN¥111.28 Million | CN¥101.82 Million | ▲ +473.9% |
| 2000 | 0.19x | CN¥27.36 Million | CN¥143.70 Million | ▲ +178.4% |
| 1999 | -0.24x | CN¥-23.08 Million | CN¥95.07 Million | ▼ -151.7% |
| 1998 | -0.10x | CN¥-2.65 Million | CN¥27.44 Million | — |